Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study.
Hilary C CraigD AlsaeedH HeneghanW Al-NajimEbaa Al OzairiCarel W le RouxPublished in: International journal of obesity (2005) (2024)
The primary concerns regarding pharmacotherapy for intentional weight loss were efficacy, side effects, lifelong dosing, pharmacokinetics, and cost. Providing access to information about all the pharmacotherapies and the benefits is likely to result in greater penetrance of treatment.
Keyphrases
- weight loss
- end stage renal disease
- bariatric surgery
- newly diagnosed
- ejection fraction
- metabolic syndrome
- type diabetes
- insulin resistance
- healthcare
- roux en y gastric bypass
- prognostic factors
- peritoneal dialysis
- weight gain
- patient reported outcomes
- emergency department
- smoking cessation
- health information
- skeletal muscle
- body mass index
- adverse drug
- replacement therapy